Shares of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) climbed 4.88% (or +$0.42) to $9.02 on..
Analysts at RBC Capital Markets reiterated a Sector Perform rating while reducing their price target..
Pain Therapeutics, Inc. (Nasdaq:PTIE) shares soared over 40% in the extended session Monday after the..
Hedge fund firm Tiger Global Management LLC disclosed Friday in a regulatory filing ( SC..
Valeant Pharmaceuticals International, Inc. (NYSE:VRX) stock surged more than 4% in the extended session Thursday after activist..